Healthcare provider profile · identity verified

Edward R Stankiewicz, MD

Internal Medicine · LINWOOD, PA · NPI 1972504066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	503	145
Amlodipine Besylate	Amlodipine Besylate	497	151
Levothyroxine Sodium	Levothyroxine Sodium	460	125
Lisinopril	Lisinopril	440	111
Gabapentin	Gabapentin	437	139
Atorvastatin Calcium	Atorvastatin Calcium	434	118
Albuterol Sulfate Hfa	Albuterol Sulfate	402	85
Montelukast Sodium	Montelukast Sodium	385	113
Rosuvastatin Calcium	Rosuvastatin Calcium	325	104
Losartan Potassium	Losartan Potassium	320	90
Simvastatin	Simvastatin	311	85
Metformin Hcl	Metformin Hcl	287	82
Azithromycin	Azithromycin	250	171
Tamsulosin Hcl	Tamsulosin Hcl	219	70
Sertraline Hcl	Sertraline Hcl	210	62
Furosemide	Furosemide	204	72
Metoprolol Succinate	Metoprolol Succinate	204	59
Methylprednisolone	Methylprednisolone	195	147
Hydrochlorothiazide	Hydrochlorothiazide	186	52
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	172	113
Metoprolol Tartrate	Metoprolol Tartrate	167	45
Quetiapine Fumarate	Quetiapine Fumarate	158	50
Pantoprazole Sodium	Pantoprazole Sodium	146	40
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	145	56
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	137	42
Potassium Chloride	Potassium Chloride	122	44
Prednisone	Prednisone	121	71
Eliquis	Apixaban	120	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	113	81
Allopurinol	Allopurinol	111	35
Meloxicam	Meloxicam	104	28
Amoxicillin	Amoxicillin	102	76
Clopidogrel	Clopidogrel Bisulfate	96	26
Donepezil Hcl	Donepezil Hcl	96	31
Buspirone Hcl	Buspirone Hcl	95	35
Topiramate	Topiramate	93	28
Fluticasone Propionate	Fluticasone Propionate	91	25
Dicyclomine Hcl	Dicyclomine Hcl	86	38
Carvedilol	Carvedilol	80	23
Famotidine	Famotidine	78	24
Hydrocortisone	Hydrocortisone	75	39
Trazodone Hcl	Trazodone Hcl	70	26
Trulicity	Dulaglutide	67	13
Levetiracetam	Levetiracetam	66	14
Metformin Hcl Er	Metformin Hcl	63	18
Ondansetron Hcl	Ondansetron Hcl	63	24
Doxycycline Hyclate	Doxycycline Hyclate	61	50
Glipizide	Glipizide	61	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	60	45
Escitalopram Oxalate	Escitalopram Oxalate	59	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	15
Pravastatin Sodium	Pravastatin Sodium	59	16
Promethazine Hcl	Promethazine Hcl	59	32
Fluconazole	Fluconazole	57	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	suppressed
Cephalexin	Cephalexin	56	45
Januvia	Sitagliptin Phosphate	56	21
Ibuprofen	Ibuprofen	54	28
Hydralazine Hcl	Hydralazine Hcl	50	14
Amitriptyline Hcl	Amitriptyline Hcl	49	14
Ezetimibe	Ezetimibe	49	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	13
Clotrimazole	Clotrimazole	48	22
Alendronate Sodium	Alendronate Sodium	47	11
Meclizine Hcl	Meclizine Hcl	47	21
Breo Ellipta	Fluticasone/Vilanterol	44	suppressed
Glipizide Er	Glipizide	44	12
Acyclovir	Acyclovir	42	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	suppressed
Naproxen	Naproxen	42	16
Hydroxyzine Hcl	Hydroxyzine Hcl	39	25
Clonidine Hcl	Clonidine Hcl	38	12
Diclofenac Sodium	Diclofenac Sodium	38	12
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Jardiance	Empagliflozin	37	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Celecoxib	Celecoxib	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Novolog Flexpen	Insulin Aspart	32	suppressed
Sucralfate	Sucralfate	30	suppressed
Atenolol	Atenolol	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Erythromycin	Erythromycin Base	25	21
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Finasteride	Finasteride	22	suppressed
Metronidazole	Metronidazole	22	15
Paxlovid	Nirmatrelvir/Ritonavir	22	21
Phenytoin Sodium Extended	Phenytoin Sodium Extended	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	20	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Calcium Acetate	Calcium Acetate	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Linzess	Linaclotide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Mupirocin	Mupirocin	17	16
Nitroglycerin	Nitroglycerin	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valsartan	Valsartan	15	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Colchicine	Colchicine	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Ozempic	Semaglutide	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error